2026 Mark C. Petrie: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	98	8724	8191	849	811	486	68727

Mark C. Petrie publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark C. Petrie sits on this spectrum.

101 publications 1,796+

This scientist: 486 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark C. Petrie D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark C. Petrie sits on this spectrum.

70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark C. Petrie is affiliated with the University of Glasgow in the United Kingdom. Their primary field of study is Medicine, with a significant focus on cardiology and cardiovascular medicine. Their research spans several subfields including Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Radiology, Nuclear Medicine and Imaging, and Hematology.

The major research topics covered in their work include:

Heart Failure Treatment and Management
Cardiovascular Function and Risk Factors
Diabetes Treatment and Management
Cardiac Imaging and Diagnostics
Cardiac pacing and defibrillation studies
Cardiac Structural Anomalies and Repair
Pancreatic function and diabetes

Among the most cited recent papers associated with or including Mark C. Petrie are:

"Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes," published in 2020 in JAMA
"Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity," published in 2023 in the New England Journal of Medicine
"Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction," published in 2022 in the New England Journal of Medicine
"Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes," published in 2024 in the New England Journal of Medicine
"Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction," published in 2024 in the New England Journal of Medicine

Frequent co-authors who have collaborated with Mark C. Petrie include:

John J.V. McMurray
Pardeep S. Jhund
Lars Køber
Kieran F. Docherty
Scott D. Solomon

Mark C. Petrie has contributed extensively to several renowned publication venues. Their frequent publication outlets are:

European Journal of Heart Failure
European Heart Journal
Journal of the American College of Cardiology
JACC Heart Failure
Circulation

Best Publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

20522
Citations
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

5382
Citations
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Christian W. Hamm;Jean-Pierre Bassand;Stefan Agewall;Jeroen Bax

1622
Citations
Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

Eric J. Velazquez;Kerry L. Lee;Marek A. Deja;Anil Jain

1392
Citations
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Søren L Kristensen;Søren L Kristensen;Rasmus Rørth;Rasmus Rørth;Pardeep S Jhund;Kieran F Docherty

1256
Citations
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy

Eric J. Velazquez;Kerry L. Lee;Robert H. Jones;Hussein R. Al-Khalidi

944
Citations
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

Karen Sliwa;Denise Hilfiker-Kleiner;Mark C. Petrie;Alexandre Mebazaa

803
Citations
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Michael R. MacDonald;Mark C. Petrie;Fumi Varyani;Jan Östergren

796
Citations
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

Nathaniel Mark Hawkins;Mark C. Petrie;Pardeep S. Jhund;George W. Chalmers

722
Citations
Randomised controlled trial of specialist nurse intervention in heart failure

Lynda Blue;Elanor Lang;John J V McMurray;Andrew P Davie

698
Citations
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferović;Mark C. Petrie;Gerasimos S. Filippatos;Stefan D. Anker

637
Citations
Clinical epidemiology of heart failure: public and private health burden.

J. J. V. Mcmurray;M. C. Petrie;D. R. Murdoch;A. P. Davie

586
Citations
Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

Eric J. Velazquez;Kerry L. Lee;Marek A. Deja;Anil Jain

512
Citations
Declining Risk of Sudden Death in Heart Failure

Li Shen;Pardeep S. Jhund;Mark C. Petrie;Mark C. Petrie;Brian L. Claggett

453
Citations
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study.

Lynn Caruana;Mark C Petrie;Andrew P Davie;John J V McMurray

436
Citations
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

435
Citations
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

John J V McMurray;David L DeMets;Silvio E Inzucchi;Lars Køber

367
Citations
Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

Michael R MacDonald;Derek T Connelly;Nathaniel M Hawkins;Tracey Steedman

349
Citations
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

Johann Bauersachs;Tobias König;Peter van der Meer;Mark C Petrie

331
Citations
Diabetes, left ventricular systolic dysfunction, and chronic heart failure

Michael R. MacDonald;Mark C. Petrie;Nathaniel M. Hawkins;John R. Petrie

325
Citations

Frequent Co-Authors

John J.V. McMurray University of Glasgow

Colin Berry University of Glasgow

Pardeep S. Jhund University of Glasgow

Keith G. Oldroyd Golden Jubilee National Hospital

Ian Ford University of Glasgow

Lars Køber Copenhagen University Hospital

Scott D. Solomon Brigham and Women's Hospital

Naveed Sattar University of Glasgow

Paul Welsh University of Glasgow

Alex McConnachie University of Glasgow

External Links

Personal website of Mark C. Petrie

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't just mean pursuing an MD. There are many online degrees and pathways that offer flexibility, speed, and affordability for professionals passionate about healthcare.

For those interested in mental health, psych np online programs are a popular route. These programs train students to become Psychiatric-Mental Health Nurse Practitioners, a field in high demand.

If you’re looking for leadership roles, a cheapest online healthcare administration degree or cheapest mha programs can prepare you for management positions in hospitals or healthcare organizations. These degrees are often designed to be affordable and accessible for working professionals.

For advanced practice nurses aiming for the highest level of clinical expertise, a 1 year dnp program online offers a fast-track option to a Doctor of Nursing Practice.

Online studies allow aspiring healthcare professionals to balance education with life’s demands, opening doors to various rewarding career pathways in medicine and health services.